Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer

Bibliographic Details
Main Authors:	Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL
Format:	Conference item
Language:	English
Published:	Springer 2017

Similar Items

Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
by: Teoh, E, et al.
Published: (2017)

Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
by: Scott, NP, et al.
Published: (2021)

Cancer imaging with fluciclovine (18F)
by: Teoh, E
Published: (2018)

Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
by: Morotti, M, et al.
Published: (2020)

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
by: Zuzana Balážová, et al.
Published: (2020-04-01)

Glutamine deprivation alters the origin and function of cancer cell exosomes
by: Fan, S, et al.
Published: (2020)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
by: Morotti, M, et al.
Published: (2019)

Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
by: Ivar S Jensen, et al.
Published: (2020-01-01)

Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
by: Tonghe Wang, et al.
Published: (2023-12-01)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
by: Dyer, A, et al.
Published: (2018)

The utilisation of glutamine and glucose by a 3-D tumour model trapped in quiescence
by: Smith, H, et al.
Published: (2021)

[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
by: Cato C. Loeff, et al.
Published: (2024-11-01)

Quantification of Equivocal Findings in F18-Fluciclovine PET/CT Scans for Biochemical Recurrence of Localized Prostate Cancer
by: Daeun Sung, et al.
Published: (2024-05-01)

18F-Fluciclovine Positron Emission Tomography in Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis
by: Giuseppina Biscontini, et al.
Published: (2021-02-01)

Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
by: Tore Bach-Gansmo, et al.
Published: (2022-06-01)

Pharmacodynamic and pharmacokinetic markers for anti-angiogenic cancer therapy: Implications for dosing and selection of patients.
by: Morotti, M, et al.
Published: (2017)

Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.
by: Hsiu-Ni Kung, et al.
Published: (2011-08-01)

Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction
by: Jun-Kai Yan, et al.
Published: (2017-03-01)

Understanding and Improving 18F-Fluciclovine PET/CT Reports: A Guide for Physicians Treating Patients with Biochemical Recurrence of Prostate Cancer
by: Benjamin H. Lowentritt, et al.
Published: (2020-01-01)

Phenylacetyl glutamine: a novel biomarker for stroke recurrence warning
by: Li Ma, et al.
Published: (2023-02-01)

Complement susceptibility in glutamine deprived breast cancer cells
by: Boackle Robert J, et al.
Published: (2007-07-01)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
by: Hui Li, et al.
Published: (2023-06-01)

Texture Analysis in [<sup>18</sup>F]-Fluciclovine PET/CT Aids to Detect Prostate Cancer Biochemical Relapse: Report of a Preliminary Experience
by: Laura Travascio, et al.
Published: (2024-04-01)

#4. Elucidating the effect of glutamine metabolism in breast-to-bone metastasis
by: Breelyn Karno, et al.
Published: (2024-04-01)

Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
by: Andreas Julius Tulipan, et al.
Published: (2018-07-01)

Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential
by: Wen Zhu, et al.
Published: (2024-06-01)

Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
by: Rui Ni, et al.
Published: (2023-03-01)

The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
by: Rang Wang, et al.
Published: (2021-06-01)

Leukemia Cells Resistant to Glutamine Deprivation Express Glutamine Synthetase Protein
by: Burcu Yücel, et al.
Published: (2022-02-01)

Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
by: Jenni Puurunen, et al.
Published: (2018-10-01)

Glutamine and glutamate supplementation raise milk glutamine concentrations in lactating gilts
by: Manso Helena, et al.
Published: (2012-02-01)

Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
by: Kawashima, M, et al.
Published: (2020)

The duality between two-index potentials and the non-linear sigma model in field theory
by: Zois, I, et al.
Published: (1996)

Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
by: Violet A. Kiesel, et al.
Published: (2022-05-01)

Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines
by: Mokgadi Violet Gwangwa, et al.
Published: (2019-03-01)

GLUTAMINE AND THE GASTROINTESTINAL-TRACT
by: Jebb, S
Published: (1995)

Diagnostic Accuracy of PET with <sup>18</sup>F-Fluciclovine ([<sup>18</sup>F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis
by: Angelo Castello, et al.
Published: (2023-12-01)

Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas: A Multicenter Phase IIb Trial
by: Toshihiko Wakabayashi, et al.
Published: (2017-01-01)

Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging With 18F- Fluciclovine: A Comparison Study With L-Methyl-11C-Methionine PET Imaging
by: Naohiro Tsuyuguchi, et al.
Published: (2017-06-01)

Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma.
by: Gareth Williams, et al.
Published: (2022-01-01)